Oppenheimer Upgrades Amgen (AMGN) to Outperform

December 17, 2025 6:38 AM UTC Send to a Friend
Oppenheimer analyst Jay Olson upgraded Amgen (NASDAQ: AMGN) from Outperform to Outperform with a price target of $380.00.The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login